{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:22:10Z","timestamp":1760898130469},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T00:00:00Z","timestamp":1330473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2407-12-79","type":"journal-article","created":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T06:14:03Z","timestamp":1330496043000},"source":"Crossref","is-referenced-by-count":5,"title":["aThe dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer"],"prefix":"10.1186","volume":"12","author":[{"given":"Gustaf","family":"Rosin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Hannelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Kere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,29]]},"reference":[{"issue":"19","key":"3101_CR1","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98 (19): 10869-10874. 10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"38","key":"3101_CR2","doi-asserted-by":"publisher","first-page":"13550","DOI":"10.1073\/pnas.0506230102","volume":"102","author":"LD Miller","year":"2005","unstructured":"Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, et al: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA. 2005, 102 (38): 13550-13555. 10.1073\/pnas.0506230102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"3101_CR3","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","volume":"20","author":"A Goldhirsch","year":"2009","unstructured":"Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn HJ: Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 2009, 20 (8): 1319-1329. 10.1093\/annonc\/mdp322.","journal-title":"Ann Oncol"},{"issue":"9","key":"3101_CR4","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1158\/1055-9965.EPI-09-0169","volume":"18","author":"C Ahlin","year":"2009","unstructured":"Ahlin C, Zhou W, Holmqvist M, Holmberg L, Nilsson C, Jirstrom K, Blomqvist C, Amini RM, Fjallskog ML: Cyclin a is a proliferative marker with good prognostic value in node-negative breast cancer. Cancer Epidemiol Biomarkers Prev. 2009, 18 (9): 2501-2506. 10.1158\/1055-9965.EPI-09-0169.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9114","key":"3101_CR5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","volume":"351","author":"Early Breast Cancer Trialists' Collaborative Group","year":"1998","unstructured":"Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998, 351 (9114): 1451-1467.","journal-title":"Lancet"},{"issue":"7","key":"3101_CR6","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1158\/1078-0432.CCR-09-1823","volume":"16","author":"SR Johnston","year":"2010","unstructured":"Johnston SR: New strategies in estrogen receptor-positive breast cancer. Clin Cancer Res. 2010, 16 (7): 1979-1987. 10.1158\/1078-0432.CCR-09-1823.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3101_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00432-008-0445-8","volume":"135","author":"YJ Kim","year":"2009","unstructured":"Kim YJ, Huh JW, Kim DS, Bae MI, Lee JR, Ha HS, Ahn K, Kim TO, Song GA, Kim HS: Molecular characterization of the DYX1C1 gene and its application as a cancer biomarker. J Cancer Res Clin Oncol. 2009, 135 (2): 265-270. 10.1007\/s00432-008-0445-8.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"3101_CR8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00432-009-0568-6","volume":"135","author":"Y Chen","year":"2009","unstructured":"Chen Y, Zhao M, Wang S, Chen J, Wang Y, Cao Q, Zhou W, Liu J, Xu Z, Tong G, et al: A novel role for DYX1C1, a chaperone protein for both Hsp70 and Hsp90, in breast cancer. J Cancer Res Clin Oncol. 2009, 135 (9): 1265-1276. 10.1007\/s00432-009-0568-6.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"20","key":"3101_CR9","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1073\/pnas.1833911100","volume":"100","author":"M Taipale","year":"2003","unstructured":"Taipale M, Kaminen N, Nopola-Hemmi J, Haltia T, Myllyluoma B, Lyytinen H, Muller K, Kaaranen M, Lindsberg PJ, Hannula-Jouppi K, et al: A candidate gene for developmental dyslexia encodes a nuclear tetratricopeptide repeat domain protein dynamically regulated in brain. Proc Natl Acad Sci USA. 2003, 100 (20): 11553-11558. 10.1073\/pnas.1833911100.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"3101_CR10","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1096\/fj.07-104455","volume":"22","author":"I Tapia-Paez","year":"2008","unstructured":"Tapia-Paez I, Tammimies K, Massinen S, Roy AL, Kere J: The complex of TFII-I, PARP1, and SFPQ proteins regulates the DYX1C1 gene implicated in neuronal migration and dyslexia. FASEB J. 2008, 22 (8): 3001-3009. 10.1096\/fj.07-104455.","journal-title":"FASEB J"},{"issue":"2","key":"3101_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.nbd.2009.06.019","volume":"38","author":"LA Gabel","year":"2010","unstructured":"Gabel LA, Gibson CJ, Gruen JR, Loturco JJ: Progress towards a cellular neurobiology of reading disability. Neurobiol Dis. 2010, 38 (2): 173-180. 10.1016\/j.nbd.2009.06.019.","journal-title":"Neurobiol Dis"},{"issue":"15","key":"3101_CR12","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/hmg\/ddp215","volume":"18","author":"S Massinen","year":"2009","unstructured":"Massinen S, Tammimies K, Tapia-Paez I, Matsson H, Hokkanen ME, Soderberg O, Landegren U, Castren E, Gustafsson JA, Treuter E, et al: Functional interaction of DYX1C1 with estrogen receptors suggests involvement of hormonal pathways in dyslexia. Hum Mol Genet. 2009, 18 (15): 2802-2812. 10.1093\/hmg\/ddp215.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"3101_CR13","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/cercor\/bhl162","volume":"17","author":"GD Rosen","year":"2007","unstructured":"Rosen GD, Bai J, Wang Y, Fiondella CG, Threlkeld SW, LoTurco JJ, Galaburda AM: Disruption of neuronal migration by RNAi of Dyx1c1 results in neocortical and hippocampal malformations. Cereb Cortex. 2007, 17 (11): 2562-2572. 10.1093\/cercor\/bhl162.","journal-title":"Cereb Cortex"},{"issue":"12","key":"3101_CR14","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1055-9965.EPI-06-0489","volume":"15","author":"LU Rosenberg","year":"2006","unstructured":"Rosenberg LU, Einarsdottir K, Friman EI, Wedren S, Dickman PW, Hall P, Magnusson C: Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2006, 15 (12): 2482-2488. 10.1158\/1055-9965.EPI-06-0489.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3-4","key":"3101_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/jnci\/88.3-4.173","volume":"88","author":"S Sjogren","year":"1996","unstructured":"Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L, Bergh J: The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst. 1996, 88 (3-4): 173-182. 10.1093\/jnci\/88.3-4.173.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"3101_CR16","doi-asserted-by":"publisher","first-page":"R953","DOI":"10.1186\/bcr1325","volume":"7","author":"Y Pawitan","year":"2005","unstructured":"Pawitan Y, Bjohle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, et al: Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005, 7 (6): R953-R964. 10.1186\/bcr1325.","journal-title":"Breast Cancer Res"},{"issue":"23","key":"3101_CR17","doi-asserted-by":"publisher","first-page":"11207","DOI":"10.1158\/0008-5472.CAN-06-0017","volume":"66","author":"J Hartman","year":"2006","unstructured":"Hartman J, Lindberg K, Morani A, Inzunza J, Strom A, Gustafsson JA: Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res. 2006, 66 (23): 11207-11213. 10.1158\/0008-5472.CAN-06-0017.","journal-title":"Cancer Res"},{"issue":"21","key":"3101_CR18","doi-asserted-by":"publisher","first-page":"10292","DOI":"10.1158\/0008-5472.CAN-05-4414","volume":"66","author":"AV Ivshina","year":"2006","unstructured":"Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, et al: Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res. 2006, 66 (21): 10292-10301. 10.1158\/0008-5472.CAN-05-4414.","journal-title":"Cancer Res"},{"issue":"5","key":"3101_CR19","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.1999.17.5.1474","volume":"17","author":"JM Harvey","year":"1999","unstructured":"Harvey JM, Clark GM, Osborne CK, Allred DC: Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999, 17 (5): 1474-1481.","journal-title":"J Clin Oncol"},{"issue":"12","key":"3101_CR20","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/modpathol.3800229","volume":"17","author":"SK Mohsin","year":"2004","unstructured":"Mohsin SK, Weiss H, Havighurst T, Clark GM, Berardo M, le Roanh D, To TV, Qian Z, Love RR, Allred DC: Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol. 2004, 17 (12): 1545-1554. 10.1038\/modpathol.3800229.","journal-title":"Mod Pathol"},{"key":"3101_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","volume":"69","author":"D Schoenfeld","year":"1982","unstructured":"Schoenfeld D: Partial residuals for the proportional hazards regression model. Biometrika. 1982, 69: 239-241. 10.1093\/biomet\/69.1.239.","journal-title":"Biometrika"},{"key":"3101_CR22","volume-title":"R: A language and environment for statistical computing","author":"R Development Core Team","year":"2009","unstructured":"R Development Core Team: R: A language and environment for statistical computing. 2009, Vienna, Austria: R Foundation for Statistical Computing"},{"issue":"4","key":"3101_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10911-006-9006-4","volume":"10","author":"C Courtillot","year":"2005","unstructured":"Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V, Kuttenn F, Kelly PA, Touraine P: Benign breast diseases. J Mammary Gland Biol Neoplasia. 2005, 10 (4): 325-335. 10.1007\/s10911-006-9006-4.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"3101_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.2808","volume":"223","author":"A Bombonati","year":"2011","unstructured":"Bombonati A, Sgroi DC: The molecular pathology of breast cancer progression. J Pathol. 2011, 223 (2): 307-317.","journal-title":"J Pathol"},{"issue":"1","key":"3101_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc2950","volume":"11","author":"V Espina","year":"2011","unstructured":"Espina V, Liotta LA: What is the malignant nature of human ductal carcinoma in situ?. Nat Rev Cancer. 2011, 11 (1): 68-75. 10.1038\/nrc2950.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3101_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, et al: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004, 6 (1): 17-32. 10.1016\/j.ccr.2004.06.010.","journal-title":"Cancer Cell"},{"issue":"37","key":"3101_CR27","doi-asserted-by":"publisher","first-page":"26767","DOI":"10.1074\/jbc.M700440200","volume":"282","author":"LA Begley","year":"2007","unstructured":"Begley LA, MacDonald JW, Day ML, Macoska JA: CXCL12 activates a robust transcriptional response in human prostate epithelial cells. J Biol Chem. 2007, 282 (37): 26767-26774. 10.1074\/jbc.M700440200.","journal-title":"J Biol Chem"},{"issue":"15","key":"3101_CR28","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2174\/156802609789895674","volume":"9","author":"S Patury","year":"2009","unstructured":"Patury S, Miyata Y, Gestwicki JE: Pharmacological targeting of the Hsp70 chaperone. Curr Top Med Chem. 2009, 9 (15): 1337-1351. 10.2174\/156802609789895674.","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"3101_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.neuroscience.2006.08.022","volume":"143","author":"Y Wang","year":"2006","unstructured":"Wang Y, Paramasivam M, Thomas A, Bai J, Kaminen-Ahola N, Kere J, Voskuil J, Rosen GD, Galaburda AM, Loturco JJ: DYX1C1 functions in neuronal migration in developing neocortex. Neuroscience. 2006, 143 (2): 515-522. 10.1016\/j.neuroscience.2006.08.022.","journal-title":"Neuroscience"},{"issue":"2","key":"3101_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10549-010-0746-x","volume":"120","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Reis-Filho JS, Ellis IO: Combinatorial biomarker expression in breast cancer. Breast Cancer Res Treat. 2010, 120 (2): 293-308. 10.1007\/s10549-010-0746-x.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3101_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991, 19 (5): 403-410. 10.1111\/j.1365-2559.1991.tb00229.x.","journal-title":"Histopathology"},{"issue":"5","key":"3101_CR32","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.2353\/ajpath.2010.100209","volume":"177","author":"T Stein","year":"2010","unstructured":"Stein T, Cosimo E, Yu X, Smith PR, Simon R, Cottrell L, Pringle MA, Bell AK, Lattanzio L, Sauter G, et al: Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am J Pathol. 2010, 177 (5): 2323-2333. 10.2353\/ajpath.2010.100209.","journal-title":"Am J Pathol"},{"issue":"5","key":"3101_CR33","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.2353\/ajpath.2010.100209","volume":"177","author":"T Stein","year":"2010","unstructured":"Stein T, Cosimo E, Yu X, Smith PR, Simon R, Cottrell L, Pringle MA, Bell AK, Lattanzio L, Sauter G, et al: Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am J Pathol. 2010, 177 (5): 2323-2333. 10.2353\/ajpath.2010.100209.","journal-title":"Am J Pathol"},{"issue":"1","key":"3101_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10456-008-9100-x","volume":"11","author":"JA Legg","year":"2008","unstructured":"Legg JA, Herbert JM, Clissold P, Bicknell R: Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis. 2008, 11 (1): 13-21. 10.1007\/s10456-008-9100-x.","journal-title":"Angiogenesis"},{"issue":"3","key":"3101_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10549-007-9504-0","volume":"106","author":"BC Schmid","year":"2007","unstructured":"Schmid BC, Rezniczek GA, Fabjani G, Yoneda T, Leodolter S, Zeillinger R: The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells. Breast Cancer Res Treat. 2007, 106 (3): 333-342. 10.1007\/s10549-007-9504-0.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3101_CR36","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1210\/en.2009-1250","volume":"151","author":"JD Keene","year":"2010","unstructured":"Keene JD: Minireview: global regulation and dynamics of ribonucleic Acid. Endocrinology. 2010, 151 (4): 1391-1397. 10.1210\/en.2009-1250.","journal-title":"Endocrinology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-12-79\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-12-79","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T10:58:51Z","timestamp":1497956331000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-12-79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,29]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["3101"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-12-79","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,29]]},"article-number":"79"}}